TABLE 1.
Patient Characteristics (N = 80)
| Male, % | 42 (53%) |
| Age at first symptom, yrs | 11.0 (6.0-13.0) |
| Age at diagnosis, yrs | 11.0 (7.4-14.0) |
| Follow-up, yrs | 6.4 (2.2-10.0) |
| Proband | 66 (83) |
| Family history of CPVT | 19 (24) |
| History of cardiac arrest | 29 (36) |
| Positive genetic testing | 49 (80) |
| RyR2 | 45 (92) |
| CASQ2 | 2 (4) |
| KCNJ2 | 2 (4) |
| Antiarrhythmic | |
| β anti-adrenergic blocker | 78 (98) |
| Flecainide | 15 (19) |
| Calcium channel blocker | 12 (15) |
| ICD (n = 49) | |
| Age at implantation, yrs | 13.5 (9.3-16.7) |
| ICD follow up | 9.0 (6.0-12.1) |
| Dual chamber | 26 (53) |
| Left cardiac sympathetic denervation | 15 (19) |
| Deaths | 3 (4) |
Values are n (%) or median (interquartile range).
CPVT = catechotaminergic polymorphic ventricular tachycardia; ICD = implantable cardioverter defibrillator.